Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HAL vs MRNA✓SelectedUSD · MRNAHAL vs MRNA performance historyLatest closeAs of-3.79%11/16
Stock and ETF performance explorer

HAL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+28.0%
MRNA return
+878.5%
Excess return
-850.5%
Maximum drawdown
-85.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.8%-3.6%-0.2%-3.7%
7D+1.9%-20.0%+21.9%+2.4%
30D-3.0%-1.3%-1.7%-3.0%
3M-5.1%+240.0%-245.1%-9.4%
6M-21.5%+339.0%-360.4%-26.0%
YTD+16.6%+630.0%-613.4%+7.2%
1Y+21.5%+769.1%-747.6%+10.8%
3Y-6.4%+181.2%-187.6%-12.7%
5Y+51.8%-8.1%+59.9%+43.1%
All+28.0%+878.5%-850.5%+7.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling